Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

25.59
-0.1132-0.44%
Post-market: 25.590.00000.00%16:10 EDT
Volume:1K
Turnover:29.50K
Market Cap:5.12M
PE:- -
High:25.59
Open:25.51
Low:25.51
Close:25.70
52wk High:27.94
52wk Low:22.63
Shares:200.00K
Float Shares:200.00K
Volume Ratio:1.52
T/O Rate:0.58%
Dividend:0.41
Dividend Rate:1.62%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly & Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 26

Novo Nordisk A/S Stock (NVO) Closed Up by 3.71% on Aug 25: A Full Analysis

TradingKey
·
Aug 26

Eli Lilly Stock (LLY) Rattled as Companies Decline to Cover Weight-Loss Drug Costs

TIPRANKS
·
Aug 26

More US Employers to Drop Weight-Loss Drugs in 2027, as Healthcare Costs Increase

Reuters
·
Aug 26

Lilly’s LY4395089 Interaction Study Marks Quiet but Important Early-Stage Progress

TIPRANKS
·
Aug 26

Novo Nordisk price target raised to DKK 275 from DKK 250 at JPMorgan

TIPRANKS
·
Aug 26

Novo Nordisk call volume above normal and directionally bullish

TIPRANKS
·
Aug 25

FDA Greenlights Roche and Eli Lilly's Blood-Based Alzheimer's Test, Setting a Single Threshold to Rule Both In and Out Amyloid Pathology

Deep News
·
Aug 25

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Aug 25

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
Aug 25

Novo Nordisk Sales Growth Could Remain Flat This Year

Dow Jones
·
Aug 25

Novo Nordisk (0QIU) Receives a Hold from Deutsche Bank

TIPRANKS
·
Aug 25

J.P. Morgan Sticks to Its Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Aug 25

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 25

Eli Lilly Stock (LLY) in Focus as Hedge Fund Titan Ken Griffin Quadruples Position

TIPRANKS
·
Aug 25

Der Aktionaer editor speculates on timing of Viking Therapeutics data

TIPRANKS
·
Aug 25

Sector Update: Healthcare

MT Newswires Live
·
Aug 25

Truist Securities Adjusts Price Target on Hims & Hers Health to $32 From $27, Keeps Hold Rating

MT Newswires Live
·
Aug 25

Novo Nordisk’s AMAZE 9 Oral Obesity Trial: A New Pill in the Weight-Loss Race

TIPRANKS
·
Aug 25

Eli Lilly’s New Obesity Drug LY3549492 Moves Forward With Completed Phase 1 Trial

TIPRANKS
·
Aug 25